{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-115592","form_type":"8-K","ticker":"LONA","cik":"0001620463","company_name":"LeonaBio, Inc.","filed_at":"2024-10-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.011118+00:00","generated_at":"2026-05-30T12:46:51.022535+00:00","sec_items":["3.01","8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Athira Pharma receives Nasdaq bid price deficiency notice; stock below $1 for 30 days","bullets":["Received Nasdaq notice on Oct 16, 2024 for non-compliance with minimum bid price of $1.00.","Has 180 calendar days (until April 14, 2025) to regain compliance by closing at $1.00+ for 10 consecutive days.","May seek stockholder approval for reverse stock split if needed to cure deficiency.","Also plans to file new $300M shelf registration S-3 to replace expiring 2021 registration.","If not compliant by deadline, may transfer to Nasdaq Capital Market for additional 180-day cure period."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-115592","json":"https://secwatch.observer/filing/0000950170-24-115592.json","markdown":"https://secwatch.observer/filing/0000950170-24-115592.md","text":"https://secwatch.observer/filing/0000950170-24-115592.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1620463/000095017024115592/0000950170-24-115592-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1620463/000095017024115592/atha-20241016.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T12:46:51.022535+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}